A Study of MIRCERA for the Intrapetient Variability of Hemoglobin Levels in Patients With Chronic Renal Anemia (RIVAL)
NCT ID: NCT01356589
Last Updated: 2017-07-05
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1288 participants
OBSERVATIONAL
2010-09-30
2012-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Patients With Chronic Kidney Disease in Pre-Dialysis or Dialysis
NCT01309295
An Observational Study of Mircera in Patients With Chronic Renal Anemia on Dialysis (CKD Stage V) or Not on Dialysis (CKD Stage III-IV)
NCT01667380
A Study of MIRCERA in Participants With Chronic Kidney Disease Stage 3-4 and Not on Dialysis
NCT02567188
An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) as Maintenance Treatment in Patients With Chronic Renal Anemia on Haemodialysis
NCT01422824
An Observational Study to Evaluate the Effectiveness of Mircera Treatment for Renal Anemia in Pre-dialysis Participants With Chronic Kideny Disease (CKD)
NCT02547454
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cohort
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Chronic kidney disease in predialysis (stage 3 and 4) and dialysis
* Renal anemia treated with Mircera according to label for at least 9 months before date of signed informed consent
Exclusion Criteria
* Contraindications to Mircera administration as per label or judged by the investigator
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hoffmann-La Roche
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clinical Trials
Role: STUDY_DIRECTOR
Hoffmann-La Roche
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Timios Stavros Clinic; Nephrology Department
Aigáleo, , Greece
General Hospital of Artas; Nephrology
Arta, , Greece
Attikon Center; Nephrology
Athens, , Greece
Athinaiki Private Clinic
Athens, , Greece
Hospital henry dunant; Nephrology
Athens, , Greece
General Hospital Hippokration of Athens; Nephrology
Athens, , Greece
General Hospital Of Athens G.Gennimatas; Nephrology
Athens, , Greece
Kyanos Stavros Private Hospital; Nephrologic Clinic
Athens, , Greece
General Hospital Of West Attikis; Nephrology
Athens, , Greece
University Hospital Attikon ; Pathology Clinic
Athens, , Greece
General Hospital Agia Olga; Nephrology
Athens, , Greece
Iaso General Private Clinic; Nephrology
Athens, , Greece
Iatriko Athinon Clinic Dafnis; Nephrology Department
Daphni-athens, , Greece
General Hospital Of Dramas; Dialysis Center Unit
Drama, , Greece
University Hospital Of Heraklion; Nefrologiki Clinic
Heraklion, , Greece
General Hospital Of Katerinis; Nephrology Unit
Katerini, , Greece
General Hospital Of Lamias; Nephrology
Lamia, , Greece
Univeristy Hospital of Larissa; Nephrology
Larissa, , Greece
Eytychios Patsidis Center Of Haemodialysis
Larissa, , Greece
General Hospital Of Leykadas; Dialysis Center Unit
Leykada, , Greece
Leivadia General Hospital; Nephrologic Clinic
Livadeia, , Greece
Kyanous Stavros of Patras, Renal Disease Therapy Unit
Pátrai, , Greece
Olympion Therapeytirion; Nefrology
Pátrai, , Greece
General Hospital Tzanio ; Nephrology
Piraeus, , Greece
General Hospital Of Chalkidikis; Dialysis Center Unit
Polygyros, , Greece
Rodos General Hospital; Nephrologic Clinic
Rhodes, , Greece
Alpha Nephrodynamiki Of Serres; Dialysis Center Unit
Serres, , Greece
Ahepa Hospital; 1St Dept. of Medicine
Thessaloniki, , Greece
IPPOKRATES Private Dialysis Centre
Thessaloniki, , Greece
General Hospital Of Thessalonikis Papageorgiou; Nephrology
Thessaloniki, , Greece
Alfa Nefrodynamiki; Nefrology
Thessaloniki, , Greece
Thessaliki Nossileytiki; Nephrology
Volos, , Greece
General Hospital of Volos; Nephrology
Volos, , Greece
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ML25289
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.